Announcements Trials

Browse Landscape

Status

Unknown 4 Recruiting 4 Terminated 1 Not yet recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 2 Breast 2 Tumor-Agnostic 1 Plasma cell 1 Other hematologic neoplasm 1 Myeloid 1 Lymphoid 1 Gynecologic 1 Dermatologic 1 CNS 1

Conditions

Neoplasm Metastasis 1

Interventions

Gemcitabine 13 pembrolizumab 12 Capecitabine 9 Irinotecan 8 Erlotinib Hydrochloride 8 Carboplatin 8 Blood Specimen Collection 8 Nivolumab 7 Docetaxel 7 Cisplatin 7 Cetuximab 7 Paclitaxel 6 Everolimus 6 130-nm albumin-bound paclitaxel 6 vadimezan 5 Magnetic Resonance Spectroscopy 5 Fluorouracil 5 Cyclophosphamide 5 trametinib 4 Leucovorin 4 Lapatinib 4 Ipilimumab 4 Bevacizumab 4 Albumin-Bound Paclitaxel 4 temsirolimus 3 atezolizumab 3 abemaciclib 3 Trastuzumab 3 Radiotherapy 3 Radiation 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Data Collection × Tumor-Agnostic × Clear all

NCT03995927 2023-06-29

PROCC

Wake Forest University Health Sciences

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡